Quince Therapeutics, Inc.QNCXNASDAQ
LOADING
|||
Switch Symbol:
Operating Income Contraction
Trending lower, below historical average, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-57.28M
↓ 22% below average
Average (7y)
$-46.85M
Historical baseline
Range
High:$-10.37M
Low:$-90.32M
CAGR
+27.7%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-57.28M | -65.5% |
| 2023 | $-34.62M | +33.4% |
| 2022 | $-52.02M | +42.4% |
| 2021 | $-90.32M | -14.5% |
| 2020 | $-78.89M | -101.4% |
| 2019 | $-39.17M | -223.2% |
| 2018 | $-12.12M | -16.9% |
| 2017 | $-10.37M | - |